- Gentilini P, Laffi G, La Villa G, Romanelli RG, Blendis LM. Asches and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? J Hepatol 1999; 31:1088-97.
- Arroyo V. Diuretic-resistant ascites in cirrhosis. Mechanism and treatment. Acta Gastroenterol BeIg 1990;53:249-55.
- Arroyo V, Gines P. Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis. Gastroenterology 1992;102:1077-157.
- Bernardi M, Blendis L, Burroughs AK, Laffi G, Rodes J, Gentilini P. Hepatorenal syndrome and ascites: questions and answers. Liver 1999;19:15-74.
- Gentilini P, Laffi G. Pathophysiology and treatment of ascites and the hepatorenal syndrome. Baillieres Clin Gastroenterol 1992:6:581-607.
- Gentilini P. Hepatorenal syndrome and ascites: an introduction. Liver 1999;19:5-14.
- Gülberg V, Bilzer M, Gerbes AL. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology 1999;30:870-5.
- Woitas RP, Heller J, Stoffel-Wagner B, Spengler U, Sauerbruch T. Renal functional reserve and nitric oxide in compensated liver cirrhosis. Hepatology 1997;26:858-64.
- Mansy H, Patel D, Tapson JS, Femandez J, Tapster S, Torrance AD, et al. Four methods to recruit renal functional reserve. Nephrol Dial Transplant 1987;2:228-32.
- Bosch JP, Saccaggi A, Lauer A, Ronco C, Belledone M, Glabman A. Renal functional reserve in humans. Effect of protein intake on glomerular filtration rate. Am J Med 1983;75: 943-50.
- Badalamenti S, Ginés P, Arroyo V, Lach J, Piera C, Rimola A, et al. Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis. Hepatology 1990;! 1: 379-86.
- Maddox DA, Brenner BM. Glomerular ultrafiltration. In: Brenner BM, Rector FC, editors. The kidney. Philadelphia: Saunders; 1991. p. 205-44.
- Bohler J, Woitas R, Keller E, Reetze-Bonorden P, Schollmeyer PJ. Effect of nifedipine and captopril on glomerular hyperfiltration in normotensive man. Am J Kidney Dis 1992;20:132-9.
- Roe JH, Epstein HJ, Goldstein NP. A photometric method for the determination of inulin in plasma and urine. J Biol Chem 1949; 178:839-45.
- Bratton EC, Marshall EK A new coupling reagent for sulfanilamide determination. J Biol Chem 1938;128:537-50.
- Green GL, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum S. Analysis of nitrate, nitrite and 15 N-nitrite in biological fluids. Anal Biochem 1982;126:131 -8.
- Battistini B, D'Orleans-Juste P, Sirois P. Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest 1993:68:600-28.
- Heller J, Kristeleit H, Brensing KA, Woitas RP, Spengler U, Sauerbruch T. Kidney function and exogenous sources are important parameters that influence the nitrite and nitrate levels in patients with cirrhosis. Scand J Gastroenterol 1999;34:297302.
- SaIo J, Femandez-Esparrach G, Gines P, Gines A, Guevara M, Sort P, et al. Urinary endothelin-like immunoreactivity in patients with cirrhosis. J Hepatol 1997;27:810-6.
- Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 1994;24:112-29.
- Jimenez W, Rodes J. Impaired responsiveness to endogenous vasoconstrictors and endothelium-derived vasoactive factors in cirrhosis (editorial; comment). Gastroenterology 1994;107: 1201-3.
- Woods LL. Mechanisms of renal hemodynamic regulation in response to protein feeding. Kidney Int 1993;44:659-75.
- Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996;111: 1002-10.
- Wong F, Massie D, Hsu P, Dudley F. Renal response to a saline load in well-compensated alcoholic cirrhosis. Gastroenterology 1994:20:873-81.
- Moreau R, Soubrane O, Sogni P, Hadengue A, Gaudin C, Lin HC, et al. Hemodynamic, neurohumoral, and metabolic responses to amino acid infusion in patients with cirrhosis. Gastroenterology 1992; 103:601-8.
- terWee PM. Renal effects of intravenous amino acid administration in humans with and without renal disease: hormonal correlates. Semin Nephrol 1995;15:426-32.
- Thomas DM, Coles GA, Williams JD. What does the renal reserve mean? Kidney Int 1994;45:411 -6.
- Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994:154:201 -5.
- Dratwa M, Burette A, Van Gossum M, Collart F, Wens R, Charlier L, et al. No rise in glomerular filtration rate after protein loading in cirrhotics. Kidney Int Suppl 1987;32:S32-4.
- Woitas RP, Stoffel-Wagner B, Flommersfeld S, Poege U, Schiedermaier P, Klehr HU, et al. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 2000;46:712-5.
- Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985:28:830-8.
- Guevara M, Gines P, Femandez-Esparrac h G, Sort P, Salmeron JM, Jiminez W, et al. Reversibility of hepatorenal syndrome by prolonged administration of omipiessin and volume expansion. Hepatology 1998:27:35-41.
- Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, et al. Acute effects of the oral administration of midodrine an a-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology 1998; 28:937-43.
- Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999;29: 1690-7.
- terWee PM, Geerlings W, Rosman JB, Sluiter WJ, van der Geest S, Donker AJM. Testing renal reserve filtration with an amino acid solution. Nephron 1985;41:193-9.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 11